Feasibility of a multifaceted implementation intervention to improve attendance at diabetic retinopathy screening in primary care in Ireland: a cluster randomised pilot trial

Fiona Riordan, Aileen Murphy, Christina Dillon, John Browne, Patricia M Kearney, Susan M Smith, Sheena M McHugh, Fiona Riordan, Aileen Murphy, Christina Dillon, John Browne, Patricia M Kearney, Susan M Smith, Sheena M McHugh

Abstract

Objectives: Diabetic retinopathy screening (DRS) uptake is suboptimal in many countries with limited evidence available on interventions to enhance DRS uptake in primary care. We investigated the feasibility and preliminary effects of an intervention to improve uptake of Ireland's national DRS programme, Diabetic RetinaScreen, among patients with type 1 or type 2 diabetes.

Design/setting: We conducted a cluster randomised pilot trial, embedded process evaluation and cost analysis in general practice, July 2019 to January 2020.

Participants: Eight practices participated in the trial. For the process evaluation, surveys were conducted with 25 staff at intervention practices. Interviews were conducted with nine staff at intervention practices, and 10 patients who received the intervention.

Interventions: The intervention comprised practice reimbursement, an audit of attendance, electronic prompts targeting professionals, General Practice-endorsed patient reminders and a patient information leaflet. Practices were randomly allocated to intervention (n=4) or wait-list control (n=4) (usual care).

Outcomes: Staff and patient interviews explored their perspectives on the intervention. Patient registration and attendance, including intention to attend, were measured at baseline and 6 months. Microcosting was used to estimate intervention delivery cost.

Results: The process evaluation identified that enablers of feasibility included practice culture and capacity to protect time, systems to organise care, and staff skills, and workarounds to improve intervention 'fit'. At 6 months, 22/71 (31%) of baseline non-attenders in intervention practices subsequently attended screening compared with 15/87 (17%) in control practices. The total delivery cost across intervention practices (patients=363) was €2509, averaging €627 per practice and €6.91 per audited patient. Continuation criteria supported proceeding to a definitive trial.

Conclusions: The Improving Diabetes Eye screening Attendance intervention is feasible in primary care; however, consideration should be given to how best to facilitate local tailoring. A definitive trial of clinical and cost-effectiveness is required with preliminary results suggesting a positive effect on uptake.

Trial registration number: NCT03901898.

Keywords: diabetes & endocrinology; diabetic retinopathy; primary care.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Improving Diabetes Eye screening Attendance (IDEAs) intervention overview; implementation strategies in italics. *Delivered by FR. HCP, Health Care Professional.
Figure 2
Figure 2
Consolidated Standards of Reporting Trials (CONSORT) flow diagram of practices and patients through the study, and timing of data collection (audit, research processes, questionnaires and interviews). *Practices were selected from 39 who expressed an interest during the recruitment period (1 month). They represented a mix of practices and we were able to sample for different practice characteristics (deprivation, size) at this point. In total, 60 practices expressed an interest in the 2-month period after the study was first advertised. βDropout: on initiating the audit the practice found it would require significantly more time than they could allocate to it, partly as many patient records had relevant data in older handwritten charts. ¶12/83 non-attenders were not deemed suitable for follow-up reminders by intervention practices.
Figure 3
Figure 3
Thematic map representing the inter-relationship between implementation outcomes. S denotes where staff-level data contributed to the theme; P denotes where patient-level data contributed. Gradients demonstrate whether themes relate to specific or multiple outcomes. Arrows indicate the directionality of influence (eg, both appropriateness and practicability influenced perceptions of acceptability). DRS, diabetic retinopathy screening.

References

    1. Sivaprasad S, Gupta B, Crosby-Nwaobi R, et al. . Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57:347–70. 10.1016/j.survophthal.2012.01.004
    1. Fong DS, Aiello L, Gardner TW, et al. . Retinopathy in diabetes. Diabetes Care 2004;27:S84–7. 10.2337/diacare.27.2007.S84
    1. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249–56. 10.1111/j.1464-5491.2009.02870.x
    1. Graham-Rowe E, Lorencatto F, Lawrenson JG, et al. . Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature. Diabet. Med.. : 2018;35:1308–19. 10.1111/dme.13686
    1. Pandey R, Morgan MM, Murphy C, et al. . Irish national diabetic RetinaScreen programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report No. 1). Br J Ophthalmol 2020. 10.1136/bjophthalmol-2020-317508. [Epub ahead of print: 17 Dec 2020].
    1. Liu Y, Zupan NJ, Swearingen R, et al. . Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study. BMJ Open 2019;9:e022594. 10.1136/bmjopen-2018-022594
    1. Powell BJ, Beidas RS, Lewis CC, et al. . Methods to improve the selection and tailoring of implementation strategies. J Behav Health Serv Res 2017;44:177–94. 10.1007/s11414-015-9475-6
    1. Zwarenstein M, Shiller SK, Croxford R, et al. . Printed educational messages aimed at family practitioners fail to increase retinal screening among their patients with diabetes: a pragmatic cluster randomized controlled trial [ISRCTN72772651]. Implement Sci 2014;9:87. 10.1186/1748-5908-9-87
    1. Legorreta AP, Hasan MM, Peters AL, et al. . An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience. Diabetes Care 1997;20:520–3. 10.2337/diacare.20.4.520
    1. Burnett S, Hurwitz B, Davey C, et al. . The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med 1998;15 Suppl 3:S38–43. 10.1002/(SICI)1096-9136(1998110)15:3+<S38::AID-DIA729>;2-T
    1. Buonaccorso KM. Diabetic retinopathy screening: a clinical quality improvement project. J Healthc Qual 1999;21:35–8. 10.1111/j.1945-1474.1999.tb01002.x
    1. Lee SJ, McCarty CA, Sicari C, et al. . Recruitment methods for community-based screening for diabetic retinopathy. Ophthalmic Epidemiol 2000;7:209–18. 10.1076/0928-6586(200009)731-VFT209
    1. Hassan S, Heinkel S, Burton A, et al. . A qualitative study exploring the barriers and facilitators of implementing a cardiovascular disease risk reducing intervention for people with severe mental illness into primary care contexts across England: the 'PRIMROSE' trial. BMC Health Serv Res 2020;20:753. 10.1186/s12913-020-05643-2
    1. Presseau J, Mackintosh J, Hawthorne G, et al. . Cluster randomised controlled trial of a theory-based multiple behaviour change intervention aimed at healthcare professionals to improve their management of type 2 diabetes in primary care. Implement Sci 2018;13:65. 10.1186/s13012-018-0754-5
    1. Lau R, Stevenson F, Ong BN, et al. . Achieving change in primary care—causes of the evidence to practice gap: systematic reviews of reviews. Implementation Sci 2015;11:40. 10.1186/s13012-016-0396-4
    1. Rushforth B, McCrorie C, Glidewell L, et al. . Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review. Br J Gen Pract 2016;66:e114–27. 10.3399/bjgp16X683509
    1. Johnston G, Crombie IK, Davies HT, et al. . Reviewing audit: barriers and facilitating factors for effective clinical audit. Qual Health Care 2000;9:23–36. 10.1136/qhc.9.1.23
    1. Riordan F, Racine E, Phillip ET, et al. . Development of an intervention to facilitate implementation and uptake of diabetic retinopathy screening. Implement Sci 2020;15:34. 10.1186/s13012-020-00982-4
    1. Eldridge SM, Lancaster GA, Campbell MJ, et al. . Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 2016;11:e0150205. 10.1371/journal.pone.0150205
    1. Riordan F, Racine E, Smith SM, et al. . Feasibility of an implementation intervention to increase attendance at diabetic retinopathy screening: protocol for a cluster randomised pilot trial. Pilot Feasibility Stud 2020;6:64. 10.1186/s40814-020-00608-y
    1. Eldridge SM, Chan CL, Campbell MJ, et al. . Consort 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016;355:i5239. 10.1136/bmj.i5239
    1. Cocks K, Torgerson DJ. Sample size calculations for pilot randomized trials: a confidence interval approach. J Clin Epidemiol 2013;66:197–201. 10.1016/j.jclinepi.2012.09.002
    1. Irish College of General Practitioners (ICGP) . A practical guide to integrated type 2 diabetes care. Dublin: Irish College of General Practitioners, 2016.
    1. Haase T. The 2016 Pobal HP deprivation index for small areas (SA) introduction and reference tables.
    1. Weiner BJ, Lewis CC, Stanick C, et al. . Psychometric assessment of three newly developed implementation outcome measures. Implement Sci 2017;12:108. 10.1186/s13012-017-0635-3
    1. Health Information and Quality Authority (HIQA) . Guidelines for the budget impact analysis of health technologies in Ireland. Dublin: HIQA, 2018.
    1. O'Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ 2010;341:c4587. 10.1136/bmj.c4587
    1. Gale NK, Heath G, Cameron E, et al. . Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013;13:1–8. 10.1186/1471-2288-13-117
    1. Sekhon M, Cartwright M, Francis JJ. Acceptability of health care interventions: A theoretical framework and proposed research agenda. Br J Health Psychol 2018;23:519–31. 10.1111/bjhp.12295
    1. Wiltsey Stirman S, Baumann AA, Miller CJ. The frame: an expanded framework for reporting adaptations and modifications to evidence-based interventions. Implement Sci 2019;14:58. 10.1186/s13012-019-0898-y
    1. Damschroder LJ, Aron DC, Keith RE, et al. . Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci 2009;4:50. 10.1186/1748-5908-4-50
    1. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res 2016;26:1753–60. 10.1177/1049732315617444
    1. Smith S, Walsh B, Wren M, et al. . Geographic profile of healthcare needs and non-acute healthcare supply in Ireland 2019.
    1. Scanlon PH. Screening intervals for diabetic retinopathy and implications for care. Curr Diab Rep 2017;17:96. 10.1007/s11892-017-0928-6
    1. Broadbent DM, Wang A, Cheyne CP, et al. . Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia 2021;64:56–69. 10.1007/s00125-020-05313-2
    1. Brouwers MC, De Vito C, Bahirathan L, et al. . What implementation interventions increase cancer screening rates? A systematic review. Implement Sci 2011;6:111. 10.1186/1748-5908-6-111
    1. Rat C, Latour C, Rousseau R, et al. . Interventions to increase uptake of faecal tests for colorectal cancer screening: a systematic review. Eur J Cancer Prev 2018;27:227–36. 10.1097/CEJ.0000000000000344
    1. Camilloni L, Ferroni E, Cendales BJ, et al. . Methods to increase participation in organised screening programs: a systematic review. BMC Public Health 2013;13:464. 10.1186/1471-2458-13-464
    1. Coronado GD, Rivelli JS, Fuoco MJ, et al. . Effect of reminding patients to complete fecal immunochemical testing: a comparative effectiveness study of automated and live approaches. J Gen Intern Med 2018;33:72–8. 10.1007/s11606-017-4184-x
    1. Kiran T, Davie S, Moineddin R, et al. . Mailed letter versus phone call to increase uptake of cancer screening: a pragmatic, randomized trial. J Am Board Fam Med 2018;31:857–68. 10.3122/jabfm.2018.06.170369
    1. Lawrenson JG, Graham-Rowe E, Lorencatto F, et al. . What works to increase attendance for diabetic retinopathy screening? an evidence synthesis and economic analysis. Health Technol Assess 2018;22:1–160. 10.3310/hta22290
    1. Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health 2020;20:1–9. 10.1186/s12889-020-09301-4
    1. Downes MJ, Mervin MC, Byrnes JM, et al. . Telephone consultations for general practice: a systematic review. Syst Rev 2017;6:128. 10.1186/s13643-017-0529-0
    1. Miller D, Loftus AM, O'Boyle PJ, et al. . Impact of a telephone-first consultation system in general practice. Postgrad Med J 2019;95:590–5. 10.1136/postgradmedj-2019-136557
    1. Ruiter RAC, Kessels LTE, Peters G-JY, et al. . Sixty years of fear appeal research: current state of the evidence. Int J Psychol 2014;49:63–70. 10.1002/ijop.12042
    1. McLean SM, Booth A, Gee M, et al. . Appointment reminder systems are effective but not optimal: results of a systematic review and evidence synthesis employing realist principles. Patient Prefer Adherence 2016;10:479–99. 10.2147/PPA.S93046
    1. Williamson MK, Pirkis J, Pfaff JJ, et al. . Recruiting and retaining GPs and patients in intervention studies: the DEPS-GP project as a case study. BMC Med Res Methodol 2007;7:42. 10.1186/1471-2288-7-42

Source: PubMed

3
Tilaa